Cargando…
REAL‐world clinical effectiveness of ivacaftor therapy in the first 24 months in two infants with cystic fibrosis and different gating mutations—A case report
This study summarizes efficacy of ivacaftor treatment in 2 infants in a real‐world setting. A distinct decline of sweat chloride and lung clearance index plus increase in fecal elastase was seen. The results underline the early and sustainable effect and give cause for discussing whether a reduction...
Autores principales: | Fuchs, Teresa, Appelt, Dorothea, Niedermayr, Katharina, Ellemunter, Helmut |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8829656/ https://www.ncbi.nlm.nih.gov/pubmed/35154718 http://dx.doi.org/10.1002/ccr3.5364 |
Ejemplares similares
-
Early and sustained improvements of lung clearance index from two to sixteen weeks of elexacaftor/tezacaftor/ivacaftor therapy in patients with cystic fibrosis—a real world study
por: Appelt, Dorothea, et al.
Publicado: (2023) -
Personalized medicine with drugs targeting the underlying protein defect in cystic fibrosis: is monitoring of treatment response necessary?
por: Niedermayr, Katharina, et al.
Publicado: (2022) -
Malignancies in patients with cystic fibrosis: a case series
por: Appelt, Dorothea, et al.
Publicado: (2022) -
Is There a Difference in Immune Response to SARS-CoV-2 Vaccination between Liver and Lung Transplant Patients with Cystic Fibrosis?
por: Fuchs, Teresa, et al.
Publicado: (2023) -
Insights Into Patient Variability During Ivacaftor-Lumacaftor Therapy in Cystic Fibrosis
por: Hanafin, Patrick O., et al.
Publicado: (2021)